Li Luo
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Extracellular vesicles in disease 4
- RNA modifications and cancer 4
- Mitochondrial Function and Pathology 3
-
- Ophthalmology and Visual Impairment Studies 2
- Co-authors
- Wei Wu (9 shared papers)Yi Wang (6 shared papers)Guixue Wang (3 shared papers)Xian Qin (3 shared papers)Yuan Zhong (5 shared papers)Ali Maruf (3 shared papers)Juhui Qiu (2 shared papers)John Antoniou (3 shared papers)
- Journals
- Theranostics (3 papers)Biomaterials (2 papers)Nature Communications (2 papers)Cochrane Database of Systematic Reviews (2 papers)Bioactive Materials (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Luo
57 papers receiving 1.8k citations
Li Luo's Hit Papers
Peers
Comparison fields: 5 of 116
- Biomaterials 305
- Cancer Research 198
- Molecular Biology 708
- Immunology 203
- Biomedical Engineering 363
Countries citing papers authored by Li Luo
This map shows the geographic impact of Li Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Luo more than expected).
Fields of papers citing papers by Li Luo
This network shows the impact of papers produced by Li Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Luo. The network helps show where Li Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications Hit paper breakdown → | 2020 | 315 |
| 2 | 2018 | 184 | |
| 3 | A Positive Feedback Loop between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression Hit paper breakdown → | 2022 | 183 |
| 4 | 2019 | 127 | |
| 5 | 2015 | 124 | |
| 6 | 2005 | 75 | |
| 7 | 2018 | 66 | |
| 8 | 2005 | 63 | |
| 9 | 2021 | 57 | |
| 10 | 2010 | 54 | |
| 11 | 2021 | 41 | |
| 12 | 2024 | 35 | |
| 13 | 2005 | 35 | |
| 14 | 2013 | 31 | |
| 15 | 2018 | 30 | |
| 16 | 2023 | 28 | |
| 17 | 2014 | 24 | |
| 18 | 2018 | 24 | |
| 19 | 2024 | 22 | |
| 20 | Platelet mitochondrial dysfunction of DM rats and DM patients. | 2015 | 22 |
About Li Luo
Li Luo is a scholar working on Molecular Biology, Epidemiology, Biomedical Engineering, Surgery and Biomaterials, having authored 63 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Extracellular vesicles in disease (4 papers), RNA modifications and cancer (4 papers), Nanoplatforms for cancer theranostics (4 papers), Bone Tissue Engineering Materials (3 papers), Mitochondrial Function and Pathology (3 papers), Ophthalmology and Visual Impairment Studies (2 papers) and Moyamoya disease diagnosis and treatment (2 papers). The work is most often cited by research in Biomaterials (305 citations), Cancer Research (198 citations), Molecular Biology (708 citations), Immunology (203 citations) and Biomedical Engineering (363 citations). Li Luo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wei Wu, Yi Wang, Guixue Wang, Xian Qin, Yuan Zhong, Ali Maruf, Juhui Qiu, John Antoniou, Fackson Mwale and Tianhan Li. Their work appears in journals such as Theranostics, Biomaterials, Nature Communications, Cochrane Database of Systematic Reviews and Bioactive Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.